The effect of endocrine-disrupting chemicals on development of breast cancer.
The effect of endocrine-disrupting chemicals on development of breast cancer.
批准号:
14571122
负责人:
KOIBUCHI Yukio
金额:
$2.11万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
It has been reported that steroid and xenobiotic receptor (SXR) is expressed in a series of breast cancer cell lines. SXR is ligand-activated transcription factor, which activates transcription through a responsive element conserved in the promoter of the cytochrome P450 (CYP) isoforms. The CYP3A4 enzymes are known to be involved in the metabolism of a wide range of xenobiotics, natural and synthetic steroids, and antisteroids, including tamoxifen (TAM). in the present study, we investigated the transcriptional regulation of CYP3A4 by SXR using transient transfection-based reporter assays in the absence band presence of ligand, such as TAM and PCB. The expression plasmid encoding SXR was cotransfected with reporter plasmid XREM-CYP3A4-Luc in MCF-7 cells, which are ER-and SXR-positive human breast cancer cell lines. These cells were treated with different concentrations of TAM and PCB (4(OH)-2',3,3',4',5'-penta chrolo biphenyl). In MCF-7 cells, 10^<-8> M TAM increased the CYP3A4 transcriptional activity, compared to 10^<-6>M TAM in CV-1, fibroblast cells. TAM and PCB activated SXR-mediated transcription of CYP3A4 in ligand and SXR dose-dependent manners. These results suggest that the induction of CYP3A4 by tamoxifen and PCB might be involved in the resistance to tamoxifen in breast cancer, and the risk of breast cancer.
期刊论文(61)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
飯野佑一, 鯉淵幸生: "乳癌治療の最前線-内分泌療法の最近の知見-"医学のあゆみ. 205. 651-655 (2003)
Yuichi Iino、Yukio Koibuchi:“乳腺癌治疗的前沿 - 内分泌治疗的最新发现”《医学史》205. 651-655 (2003)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
飯野祐一, 鯉淵幸生: "GnRHアンタゴニストの臨床応用-乳癌-"産科と婦人科. 71. 321-326 (2004)
Yuichi Iino,Yukio Koibuchi:“GnRH 拮抗剂的临床应用 - 乳腺癌 -” 妇产科 71. 321-326 (2004)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
飯野佑一, 鯉淵幸生, 吉田 崇: "目で見る性ホルモン依存性疾患の診断と治療-乳癌-"Hormone frontier in gynecology. 9. 318-321 (2002)
Yuichi Iino、Yukio Koibuchi、Takashi Yoshida:“性激素依赖性疾病的视觉诊断和治疗 - 乳腺癌”妇科激素前沿。 9. 318-321 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Koibuchi N, Jingu H, Iwasaki T, Chin WW: "Current perspectives on the role of thyroid hormone in growth and development of cerebellum"Cerebellum. 2. 279-289 (2003)
Koibuchi N、Jingu H、Iwasaki T、Chin WW:“甲状腺激素在小脑生长和发育中的作用的当前观点”小脑。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
鯉淵幸生: "LH-RH agonistの効用(乳癌の最新医療 小山博記, 霞 富士雄(監修))"先端医療技術研究所. 276-279 (2003)
小渕幸雄:“LH-RH激动剂的功效(乳腺癌的最新治疗方法;小山弘树、霞富士夫(导师))”先进医疗技术研究所276-279(2003)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 26 条
Development of the growth enhancing matrix of Reef building corals by using a feeble electrochemical method
-
批准号:19686032
-
项目类别:Grant-in-Aid for Young Scientists (A)
-
资助金额:$12.23万
-
财政年份:2007
-
负责人:KOIBUCHI Yukio
-
依托单位:
EFFECTS OF ENDOCRINE DISRUPTING CHEMICALS ON THE PROGRESSION OF BREAST CANCER -ITAIMS AT THE DEVELOPMENT OF ANOVEL REMOVAL METHOD AND TREATMENT
-
批准号:18591429
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.47万
-
财政年份:2006
-
负责人:KOIBUCHI Yukio
-
依托单位:
Tamoxifen activates CYP3A4 and MDR-1 genes through steroid and xenobiotic receptor in breast cancer cells.
-
批准号:16591247
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2004
-
负责人:KOIBUCHI Yukio
-
依托单位:
国内基金
海外基金
维生素K2通过SXR调控matrilin-2促进卵圆细胞增殖介导肝再生的研究
-
批准号:81041099
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2010
-
负责人:李明意
-
依托单位:
应用SXR-CT技术实时观测固相烧结的微结构演化过程
-
批准号:10472113
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2004
-
负责人:胡小方
-
依托单位:
基于人SXR/CYP3A4系统的转基因斑马鱼的建立与研究
-
批准号:30370802
-
项目类别:面上项目
-
资助金额:21.0万元
-
批准年份:2003
-
负责人:黎怀星
-
依托单位: